Tracker

ETF universe handoff

Opening ETF evidence benchSynchronizing prices, risk metrics, holdings coverage, and source lineage

Company context

Medtronic plc.

NYSE:MDT

Medical Specialties · benchmarked against Medical Specialties inside the XLV constituent company universe.

Active tabFinancial reports

Current readMixed

Last close82.89

1M return-0.21%

Open symbol page Watchlist context

OverviewVerdict, thesis map, and valuation setup.FundamentalsDrivers, trajectory, and business quality.Financial reportsStatement tables, sorting, filtering, and acceleration.Ex-ante forecastTarget price, dividend yield, and total return by horizon.FactorsCompany factor exposure, rank, and universe context.Market viewMomentum, catalysts, charts, and symbol packet.AttributionLarge-move causes, residuals, and research backlog.OwnershipSEC 13F holder flow, crowding, and manager changes.PeersPeer heatmap and closest comparables.

Tab scope

Raw financial statements

Financial reports

Source and lookbackStored financial report rows12 report snapshots; latest report Jun 24, 6:22 PM GMT+8.

Sample and caveat28 reported metrics across 4 sections.Use this tab for its stated job; heavier model packets stay on their own tabs.

Traditional statement tables

Financial reports

12 reports · latest Jun 24, 6:22 PM GMT+8

Distinct report rows12

Sections4

Metrics28

Coverage100%

CompanyMedtronic plc.

Overview scoring

Fundamental overview

61/100 blended · 96/100 confidence · benchmark Closest peers

Blended fundamental score: Earnings 63/100; Cash flow 57/100; Balance sheet 51/100; Valuation 76/100.

Broad comparison

Cohort scorecard

Coverage-adjusted score with thinner cohorts automatically down-weighted

Cohort scorecard: Closest peers 62/100; Medical Specialties 63/100; Health Technology 57/100; XLV constituent company universe 56/100.

Selected company rank

Rank and percentile

Confidence-adjusted standing inside each cohort

Rank and percentile: Closest peers #1 of 13; Medical Specialties #2 of 24; Health Technology #11 of 41; XLV constituent company universe #15 of 59.

Section scoring matrix

Earnings, cash flow, balance sheet, and valuation

Heatmap score by cohort and statement section

Section scoring matrix: Closest peers Earnings 64/100; Cash flow 57/100; Balance sheet 54/100; Valuation 79/100.

Sort byFilter metrics

Specialist report review

Quant, PM, and risk-manager reads

Deterministic review lanes from stored report metrics

Quant review

Favorable acceleration9/21

Current / quick gap has the largest second-order move at -30.41%. 9 metrics are accelerating favorably and 12 are decelerating.

Fundamental PM review

Growth and cash quality5/5

EPS TTM is 3.73 with +4.02% latest change. The PM lane checks revenue, EPS, cash flow, and margin confirmation together.

Risk manager review

Risk controls need review3 watch items

Debt / Equity is 0.59 with +2.83% latest change. The risk lane checks leverage, liquidity, and cash-yield deterioration.

Indexed report history

Financial report trend chart

First visible report = 100

Financial report trend chart: Total revenue 36.4B; Revenue quarter 9.8B; Revenue next quarter 9.6B; Operating income TTM 7B.

Second order change

Acceleration chart

Favorable acceleration means the latest move improved versus the prior move

Acceleration chart: Total revenue +13.91%; Revenue quarter +8.14%; Operating income TTM +8.64%; Operating margin -5.63%.

PM / risk lens

Risk and quality radar

Directional score from change and acceleration

Risk and quality radar: Growth 67/100; Cash 40/100; Quality 65/100; Balance 16/100; Valuation 53/100.

Earnings

Metric trend table

10 of 10 metrics shown

Metric	Latest	Change	Acceleration	Trend	Samples
Total revenueRevenue	36.4B	+8.43%+2.8B	+13.91%+4.8B	accelerating	12
Revenue quarterRevenue	9.8B	+8.76%+790M	+8.14%+734M	accelerating	11
Revenue next quarterRevenue	9.6B	-0.82%-79.1M	Need 3 reportsNeed 3 reports	stable	2
Operating income TTMEarnings	7B	+8.61%+557M	+8.64%+559M	accelerating	11
Operating marginProfitability	+19.32%	+0.17%+0.03 pts	-5.63%-1.03 pts	decelerating	12
EPS TTMEarnings	3.73	+4.02%+0.14	Need 3 reportsNeed 3 reports	improving	2
EPS next quarterEarnings	1.39	-10.23%-0.16	Need 3 reportsNeed 3 reports	deteriorating	2
Gross marginQuality	+60.27%	+1.14%+0.68 pts	+1.73%+1.03 pts	accelerating	11
Net marginQuality	+13.21%	+1.51%+0.20 pts	+6.64%+0.90 pts	accelerating	11
Gross-to-net conversionQuality	+21.91%	+0.37%+0.08 pts	+0.37%+0.08 pts	stable	12

Historical statement rows

Earnings report history

12 dated rows

Snapshot date	Total revenue	Revenue quarter	Revenue next quarter	Operating income TTM	Operating margin	EPS TTM	EPS next quarter	Gross margin	Net margin	Gross-to-net conversion
Nov 6, 2023	32B	8B	—	5.8B	+18.17%	—	—	+60.20%	+12.84%	+21.32%
Feb 5, 2024	32.3B	8.1B	—	6B	+18.50%	—	—	+60.32%	+13.00%	+21.55%
May 6, 2024	32.4B	8.6B	—	5.8B	+17.93%	—	—	+60.35%	+11.36%	+18.82%
Aug 5, 2024	32.6B	7.9B	—	5.8B	+17.95%	—	—	+60.13%	+12.05%	+20.05%
Nov 4, 2024	33B	8.4B	—	5.9B	+17.93%	—	—	+60.08%	+12.99%	+21.63%
Feb 3, 2025	33.2B	8.3B	—	6.2B	+18.65%	—	—	+60.32%	+12.83%	+21.27%
May 5, 2025	33.5B	8.9B	—	6.2B	+18.38%	—	—	+59.79%	+13.90%	+23.25%
Aug 4, 2025	34.2B	8.6B	—	6.3B	+18.47%	—	—	+59.81%	+13.63%	+22.78%
Nov 3, 2025	34.8B	9B	—	6.5B	+18.61%	—	—	+59.95%	+13.71%	+22.87%
Feb 2, 2026	35.5B	9B	—	6.5B	+18.23%	—	—	+59.59%	+13.01%	+21.83%
Apr 17, 2026	33.5B	9B	9.6B	6.5B	+19.29%	3.58	1.55	+59.59%	+13.01%	+21.83%
Jun 24, 2026	36.4B	9.8B	9.6B	7B	+19.32%	3.73	1.39	+60.27%	+13.21%	+21.91%